Jochen H. Lorch

10.4k citations
121 papers · 5.4k · 4 hit papers · h-index 32

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Polyomavirus and related diseases

Papers in

    • Cancer Immunotherapy and Biomarkers 14
    • Ear and Head Tumors 9
    • Cancer Diagnosis and Treatment 9
    • Head and Neck Cancer Studies 41

Jochen H. Lorch

114 papers receiving 5.3k citations

Jochen H. Lorch's Hit Papers

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial 2016 · 933 citations
9330+5+10Years since publication250500750

Peers

Jochen H. Lorch
Comparison fields: 5 of 112
  • Otorhinolaryngology 1.8k
  • Oncology 2.9k
  • Cancer Research 520
  • Surgery 1.5k
  • Periodontics 146
Replace Jaana Hagström with:
Jaana Hagström Finland
Cécile Badoual France
B Luboïnski France
Glenn J. Hanna United States
Uta Drebber Germany
Renata Ferrarotto United States
Amanda Psyrri Greece
J. Guigay France
Jonathan D. Schoenfeld United States
Sandra Nuyts Belgium
Jochen H. Lorch relative to Jaana Hagström Finland Jaana Hagström's profile →
Citations per field
00.5×1.5×2.0×
Jaana Hagström · 1×
Citations per year

Countries citing papers authored by Jochen H. Lorch

Since Specialization
Citations

This map shows the geographic impact of Jochen H. Lorch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen H. Lorch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen H. Lorch more than expected).

Fields of papers citing papers by Jochen H. Lorch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen H. Lorch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen H. Lorch. The network helps show where Jochen H. Lorch may publish in the future.

Co-authors

The 25 scholars most cited alongside Jochen H. Lorch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jochen H. Lorch Line = papers co-authored together Jochen H. Lorch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Hit paper breakdown →
2016933
2
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Hit paper breakdown →
2013486
3
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
Hit paper breakdown →
2011353
4
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
Hit paper breakdown →
2011310
5 2018235
6 2014234
7 2009221
8 2015208
9 2018200
10 2013132
11 2004125
12 2020104
13 201095
14 201474
15 201671
16 201768
17 201157
18 200752
19 201952
20 202051

About Jochen H. Lorch

Jochen H. Lorch is a scholar working on Oncology, Otorhinolaryngology, Surgery, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 121 papers that have together received 5.4k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (41 papers), Thyroid Cancer Diagnosis and Treatment (27 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers), Cancer Immunotherapy and Biomarkers (14 papers), Head and Neck Surgical Oncology (11 papers), Lung Cancer Treatments and Mutations (10 papers), Ear and Head Tumors (9 papers) and Cancer Diagnosis and Treatment (9 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Oncology (2.9k citations), Cancer Research (520 citations), Surgery (1.5k citations) and Periodontics (146 citations). Jochen H. Lorch has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert I. Haddad, Marshall R. Posner, Nicholas J. Sarlis, Roy B. Tishler, Glenn J. Hanna, Olga Goloubeva, Kevin J. Cullen, Patrick Terheyden, Karl D. Lewis and Paul Nghiem. Their work appears in journals such as Journal of Clinical Oncology, Oral Oncology, Head & Neck, International Journal of Radiation Oncology*Biology*Physics and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact